About Our Team
Our team consists of scientists and entrepreneurs with extensive experience in protein interaction technologies, cell signaling and systems biology. We use our platform technology and expertise to decipher more complete and accurate protein-protein interactomes to accelerate your research and product development.
We have helped our clients with a variety of complex, high impact, difficult projects including the screening for novel tumor suppressor targets, PPIs in hearing disorders, interaction mappings for novel isoforms, plant interaction networks, among other state-of-the-art projects.
Our Team

Bernhard Suter
CEO and Co-Founder

Evelin Szakal
CFO and VP of Business Development

Ann Holtz-Morris
Senior Scientist

Rich Yu
Scientific advisor

Andrew Mendelsohn
Advisor & Co-founder
Consult our Protein Interaction Screening Experts.
Contact Next Interactions for advice from our scientists about the best approach for elucidating the protein interactions you need to understand for your research. We can advise you on methods such as the NGS-yeast two-hybrid system, yeast two-hybrid system, how to compliment interactome coverage by mass spectrometry, and more.